{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:30Z","timestamp":1786982190215,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Council of Scientific and Industrial Research, Government of India.","award":["MLP-2035"],"award-info":[{"award-number":["MLP-2035"]}]},{"name":"Science and Engineering Research Board, Government of India","award":["SPR\/2019\/000346"],"award-info":[{"award-number":["SPR\/2019\/000346"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04180-4","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:44:40Z","timestamp":1738925080000},"page":"581-596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Multifaceted skeletal effects of sevelamer carbonate in a secondary hyperparathyroidism model"],"prefix":"10.1007","volume":"88","author":[{"given":"Shivani","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manendra Singh","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreyanko","family":"Sadhukhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konica","family":"Porwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajdeep","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaur R.","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naibedya","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"4180_CR1","doi-asserted-by":"publisher","first-page":"12223","DOI":"10.3390\/ijms232012223","volume":"23","author":"L Hu","year":"2022","unstructured":"L. Hu, A. Napoletano, M. Provenzano, C. Garofalo, C. Bini, G. Comai, G. La Manna, Mineral bone disorders in kidney disease patients: the ever-current topic. Int. J. Mol. Sci. 23, 12223 (2022). https:\/\/doi.org\/10.3390\/ijms232012223","journal-title":"Int. J. Mol. Sci."},{"key":"4180_CR2","doi-asserted-by":"publisher","first-page":"e16388","DOI":"10.7759\/cureus.16388","volume":"13","author":"E Habas Sr.","year":"2021","unstructured":"E. Habas Sr., M. Eledrisi, F. Khan, A.Y. Elzouki, Secondary hyperparathyroidism in chronic kidney disease: pathophysiology and management. Cureus 13, e16388 (2021). https:\/\/doi.org\/10.7759\/cureus.16388.","journal-title":"Cureus"},{"key":"4180_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/pharmacy11010027","volume":"11","author":"P Nain","year":"2023","unstructured":"P. Nain, N. Nayak, M.C. Maj, R.K. Singh, J. Kaur, Y. Jeong, S. Maity, R. Nath, R.H. Hilgers, S. Nauhria, S. Nauhria, Efficacy of lanthanum carbonate and sevelamer carbonate as phosphate binders in chronic kidney disease-a comparative clinical study. Pharmacy 11, 27 (2023). https:\/\/doi.org\/10.3390\/pharmacy11010027","journal-title":"Pharmacy"},{"key":"4180_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/sdi.12388","volume":"28","author":"SM Ott","year":"2015","unstructured":"S.M. Ott, Pharmacology of bisphosphonates in patients with chronic kidney disease. Semin. Dial. 28, 363\u2013369 (2015). https:\/\/doi.org\/10.1111\/sdi.12388","journal-title":"Semin. Dial."},{"key":"4180_CR5","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/jbmr.4235","volume":"36","author":"DE Robinson","year":"2021","unstructured":"D.E. Robinson, M.S. Ali, N. Pallares, C. Teb\u00e9, L. Elhussein, B. Abrahamsen, N.K. Arden, Y. Ben-Shlomo, F.J. Caskey, C. Cooper, D. Dedman, A. Delmestri, A. Judge, M.J. P\u00e9rez-S\u00e1ez, J. Pascual, X. Nogues, A. Diez-Perez, V.Y. Strauss, M.K. Javaid, D. Prieto-Alhambra, Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis. J. Bone Miner. Res. 36, 820\u2013832 (2021). https:\/\/doi.org\/10.1002\/jbmr.4235","journal-title":"J. Bone Miner. Res."},{"key":"4180_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1001\/jama.2023.28239","volume":"331","author":"ST Bird","year":"2024","unstructured":"S.T. Bird, E.R. Smith, K. Gelperin, T.H. Jung, A. Thompson, R. Kambhampati, H. Lyu, H. Zhao, Y. Zhao, Y. Zhu, O. Easley, A. Niak, M. Wernecke, Y. Chillarige, M. Zemskova, J.A. Kelman, D.J. Graham, Severe hypocalcemia with denosumab among older female dialysis-dependent patients. Jama 331, 491\u2013499 (2024). https:\/\/doi.org\/10.1001\/jama.2023.28239","journal-title":"Jama"},{"key":"4180_CR7","doi-asserted-by":"publisher","first-page":"6846","DOI":"10.3390\/ijms21186846","volume":"21","author":"CY Hsu","year":"2020","unstructured":"C.Y. Hsu, L.R. Chen, K.H. Chen, Osteoporosis in patients with chronic kidney diseases: a systemic review. Int. J. Mol. Sci. 21, 6846 (2020). https:\/\/doi.org\/10.3390\/ijms21186846","journal-title":"Int. J. Mol. Sci."},{"key":"4180_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/1744-9987.14177","volume":"28","author":"M Zaimi","year":"2024","unstructured":"M. Zaimi, E. Grapsa, Current therapeutic approach of chronic kidney disease-mineral and bone disorder. Ther. Apher. Dial. 28, 671\u2013689 (2024). https:\/\/doi.org\/10.1111\/1744-9987.14177","journal-title":"Ther. Apher. Dial."},{"key":"4180_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12882-018-1037-8","volume":"19","author":"JO Burton","year":"2018","unstructured":"J.O. Burton, D.J. Goldsmith, N. Ruddock, R. Shroff, M. Wan, Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD. BMC Nephrol. 19, 240 (2018). https:\/\/doi.org\/10.1186\/s12882-018-1037-8","journal-title":"BMC Nephrol."},{"key":"4180_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00467-012-2381-8","volume":"28","author":"K Wesseling-Perry","year":"2013","unstructured":"K. Wesseling-Perry, I.B. Salusky, Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children. Pediatr. Nephrol. 28, 617\u2013625 (2013). https:\/\/doi.org\/10.1007\/s00467-012-2381-8","journal-title":"Pediatr. Nephrol."},{"key":"4180_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/nep.13457","volume":"23","author":"YC Hou","year":"2018","unstructured":"Y.C. Hou, C.L. Lu, K.C. Lu, Mineral bone disorders in chronic kidney disease. Nephrology 23, 88\u201394 (2018). https:\/\/doi.org\/10.1111\/nep.13457","journal-title":"Nephrology"},{"key":"4180_CR12","doi-asserted-by":"publisher","first-page":"c108","DOI":"10.1159\/000337087","volume":"120","author":"JM Fraz\u00e3o","year":"2012","unstructured":"J.M. Fraz\u00e3o, T. Adrag\u00e3o, Non-calcium-containing phosphate binders: comparing efficacy, safety, and other clinical effects. Nephron Clin. Pract. 120, c108\u2013c119 (2012). https:\/\/doi.org\/10.1159\/000337087","journal-title":"Nephron Clin. Pract."},{"key":"4180_CR13","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1111\/j.1523-1755.2005.00753.x","volume":"68","author":"E Slatopolsky","year":"2005","unstructured":"E. Slatopolsky, H. Liapis, J. Finch, Progressive accumulation of lanthanum in the liver of normal and uremic rats. Kidney Int. 68, 2809\u20132813 (2005). https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00753.x","journal-title":"Kidney Int."},{"key":"4180_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.18773\/austprescr.2017.002","volume":"40","author":"S Chan","year":"2017","unstructured":"S. Chan, K. Au, R.S. Francis, D.W. Mudge, D.W. Johnson, P.I. Pillans, Phosphate binders in patients with chronic kidney disease. Aust. Prescr. 40, 10\u201314 (2017). https:\/\/doi.org\/10.18773\/austprescr.2017.002","journal-title":"Aust. Prescr."},{"key":"4180_CR15","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/ph7100990","volume":"7","author":"A Gupta","year":"2014","unstructured":"A. Gupta, Ferric citrate hydrate as a phosphate binder and risk of aluminum toxicity. Pharmaceuticals 7, 990\u2013998 (2014). https:\/\/doi.org\/10.3390\/ph7100990","journal-title":"Pharmaceuticals"},{"key":"4180_CR16","first-page":"22","volume":"15","author":"S Spaia","year":"2011","unstructured":"S. Spaia, Phosphate binders: sevelamer in the prevention and treatment of hyperphosphataemia in chronic renal failure. Hippokratia 15, 22\u201326 (2011)","journal-title":"Hippokratia"},{"key":"4180_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1523-1755.2003.00126.x","volume":"64","author":"K Katsumata","year":"2003","unstructured":"K. Katsumata, K. Kusano, M. Hirata, K. Tsunemi, N. Nagano, S.K. Burke, N. Fukushima, Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int. 64, 441\u2013450 (2003). https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00126.x","journal-title":"Kidney Int."},{"key":"4180_CR18","doi-asserted-by":"publisher","first-page":"e0133938","DOI":"10.1371\/journal.pone.0133938","volume":"10","author":"C Wang","year":"2015","unstructured":"C. Wang, X. Liu, Y. Zhou, S. Li, Y. Chen, Y. Wang, T. Lou, New conclusions regarding comparison of sevelamer and calcium-based phosphate binders in coronary-artery calcification for dialysis patients: a meta-analysis of randomized controlled trials. PLoS One 10, e0133938 (2015). https:\/\/doi.org\/10.1371\/journal.pone.0133938","journal-title":"PLoS One"},{"key":"4180_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2023.2210230","volume":"45","author":"Q Zeng","year":"2023","unstructured":"Q. Zeng, Y. Zhong, X. Yu, Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients. Ren. Fail. 45, 2210230 (2023). https:\/\/doi.org\/10.1080\/0886022x.2023.2210230","journal-title":"Ren. Fail."},{"key":"4180_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1592\/phco.29.5.554","volume":"29","author":"AB Pai","year":"2009","unstructured":"A.B. Pai, B.M. Shepler, Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications. Pharmacotherapy 29, 554\u2013561 (2009). https:\/\/doi.org\/10.1592\/phco.29.5.554","journal-title":"Pharmacotherapy"},{"key":"4180_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00467-009-1328-1","volume":"25","author":"E Gonzalez","year":"2010","unstructured":"E. Gonzalez, J. Schomberg, N. Amin, I.B. Salusky, J. Zaritsky, Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients. Pediatr. Nephrol 25, 373\u2013375 (2010). https:\/\/doi.org\/10.1007\/s00467-009-1328-1","journal-title":"Pediatr. Nephrol"},{"key":"4180_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/2040622311433771","volume":"3","author":"M Cozzolino","year":"2012","unstructured":"M. Cozzolino, M.A. Rizzo, A. Stucchi, D. Cusi, M. Gallieni, Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective. Ther. Adv. Chronic Dis. 3, 59\u201368 (2012). https:\/\/doi.org\/10.1177\/2040622311433771","journal-title":"Ther. Adv. Chronic Dis."},{"key":"4180_CR23","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1093\/ndt\/gfp372","volume":"24","author":"S Fan","year":"2009","unstructured":"S. Fan, C. Ross, S. Mitra, P. Kalra, J. Heaton, J. Hunter, M. Plone, N. Pritchard, A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis. Nephrol. Dial. Transplant. 24, 3794\u20133799 (2009). https:\/\/doi.org\/10.1093\/ndt\/gfp372","journal-title":"Nephrol. Dial. Transplant."},{"key":"4180_CR24","doi-asserted-by":"publisher","first-page":"e0163022","DOI":"10.1371\/journal.pone.0163022","volume":"11","author":"J Jokihaara","year":"2016","unstructured":"J. Jokihaara, I.H. P\u00f6rsti, H. Siev\u00e4nen, P. K\u00f6\u00f6bi, P. Kannus, O. Niemel\u00e4, R.T. Turner, U.T. Iwaniec, T.L. J\u00e4rvinen, Phosphate binding with sevelamer preserves mechanical competence of bone despite acidosis in advanced experimental renal insufficiency. PLoS One 11, e0163022 (2016). https:\/\/doi.org\/10.1371\/journal.pone.0163022","journal-title":"PLoS One"},{"key":"4180_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000527833","volume":"9","author":"W Chen","year":"2023","unstructured":"W. Chen, H.F. Liu, Q.K. Chen, M.H. Zhao, X.N. Chen, H. Liu, J.X. Wan, S.M. Li, M.H. Chen, C. Dai, H.B. Shi, J.L. Wei, H.W. Zhao, L.H. Wang, G. Long, W.H. Lu, Y. Tang, J.W. Yang, L.Y. Cao, D.X. Tang, Y.Q. Yang, X.Q. Yu, Efficacy and safety of sevelamer carbonate in chinese nondialysis chronic kidney disease patients with hyperphosphatemia: a randomized, double-blind, parallel-group study. Kidney Dis. 9, 82\u201393 (2023). https:\/\/doi.org\/10.1159\/000527833","journal-title":"Kidney Dis."},{"key":"4180_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00223-016-0178-7","volume":"99","author":"E Neven","year":"2016","unstructured":"E. Neven, B. Opdebeeck, A. De Mar\u00e9, R. Bashir-Dar, G. Dams, R. Marynissen, G.J. Behets, A. Verhulst, B.L. Riser, P.C. D\u2019Haese, Can intestinal phosphate binding or inhibition of hydroxyapatite growth in the vascular wall halt the progression of established aortic calcification in chronic kidney disease? Calcif. Tissue Int. 99, 525\u2013534 (2016). https:\/\/doi.org\/10.1007\/s00223-016-0178-7","journal-title":"Calcif. Tissue Int."},{"key":"4180_CR27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2147\/tcrm.s64657","volume":"11","author":"L Meng","year":"2015","unstructured":"L. Meng, B. Fu, Practical use of sevelamer in chronic kidney disease patients on dialysis in People\u2019s Republic of China. Ther. Clin. Risk Manag. 11, 705\u2013712 (2015). https:\/\/doi.org\/10.2147\/tcrm.s64657","journal-title":"Ther. Clin. Risk Manag."},{"key":"4180_CR28","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2215\/cjn.05161107","volume":"3","author":"M Ketteler","year":"2008","unstructured":"M. Ketteler, M. Rix, S. Fan, N. Pritchard, O. Oestergaard, S. Chasan-Taber, J. Heaton, A. Duggal, P.A. Kalra, Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis. Clin. J. Am. Soc. Nephrol. 3, 1125\u20131130 (2008). https:\/\/doi.org\/10.2215\/cjn.05161107","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"4180_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ddmod.2010.08.002","volume":"7","author":"HC Yang","year":"2010","unstructured":"H.C. Yang, Y. Zuo, A.B. Fogo, Models of chronic kidney disease. Drug. Discov. Today Dis. Models 7, 13\u201319 (2010). https:\/\/doi.org\/10.1016\/j.ddmod.2010.08.002","journal-title":"Drug. Discov. Today Dis. Models"},{"key":"4180_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/toxins13070503","volume":"13","author":"IF Duayer","year":"2021","unstructured":"I.F. Duayer, E.J. Duque, C.K. Fujihara, I.B. de Oliveira, L.M. Dos Reis, F.G. Machado, F.G. Graciolli, V. Jorgetti, R. Zatz, R.M. Elias, R.M.A. Moys\u00e9s, The protein-independent role of phosphate in the progression of chronic kidney disease. Toxins 13, 503 (2021). https:\/\/doi.org\/10.3390\/toxins13070503","journal-title":"Toxins"},{"key":"4180_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117126","volume":"185","author":"S Sharma","year":"2024","unstructured":"S. Sharma, S. Kumar, M.S. Tomar, D. Chauhan, C. Kulkarni, S. Rajput, S. Sadhukhan, K. Porwal, R. Guha, A. Shrivastava, J.R. Gayen, N. Kumar, N. Chattopadhyay, Multiscale effects of the calcimimetic drug, etelcalcetide on bone health of rats with secondary hyperparathyroidism induced by chronic kidney disease. Bone 185, 117126 (2024). https:\/\/doi.org\/10.1016\/j.bone.2024.117126","journal-title":"Bone"},{"key":"4180_CR32","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1039\/d1fo03867b","volume":"13","author":"S Sharma","year":"2022","unstructured":"S. Sharma, K. Porwal, C. Kulkarni, S. Pal, P. Sihota, S. Kumar, M.C. Tiwari, R. Katekar, A. Kumar, P. Singh, S. Rajput, R. Guha, N. Kumar, J.R. Gayen, N. Chattopadhyay, Diosmin, a citrus fruit-derived phlebotonic bioflavonoid protects rats from chronic kidney disease-induced loss of bone mass and strength without deteriorating the renal function. Food Funct. 13, 2184\u20132199 (2022). https:\/\/doi.org\/10.1039\/d1fo03867b","journal-title":"Food Funct."},{"key":"4180_CR33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1021\/acsptsci.3c00028","volume":"6","author":"MS Tomar","year":"2023","unstructured":"M.S. Tomar, A. Sharma, F. Araniti, A. Pateriya, A. Shrivastava, A.K. Tamrakar, Distinct metabolomic profiling of serum samples from high-fat-diet-induced insulin-resistant mice. ACS pharmacol. Transl. Sci. 6, 771\u2013782 (2023). https:\/\/doi.org\/10.1021\/acsptsci.3c00028","journal-title":"ACS pharmacol. Transl. Sci."},{"key":"4180_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1026848","volume":"9","author":"Mohit","year":"2022","unstructured":"Mohit, M.S. Tomar, F. Araniti, A. Pateriya, R.A. Singh Kushwaha, B.P. Singh, S.K. Jurel, R.D. Singh, A. Shrivastava, P. Chand, Identification of metabolic fingerprints in severe obstructive sleep apnea using gas chromatography-Mass spectrometry. Front. Mol. Biosci. 9, 1026848 (2022). https:\/\/doi.org\/10.3389\/fmolb.2022.1026848","journal-title":"Front. Mol. Biosci."},{"key":"4180_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110373","volume":"373","author":"KR Washimkar","year":"2023","unstructured":"K.R. Washimkar, M.S. Tomar, S. Ishteyaque, A. Kumar, A. Shrivastava, M.N. Mugale, Benzo[a]pyrene treatment modulates Nrf2\/Keap1 axis and changes the metabolic profile in rat lung cancer. Chem. Biol. Interact 373, 110373 (2023). https:\/\/doi.org\/10.1016\/j.cbi.2023.110373","journal-title":"Chem. Biol. Interact"},{"key":"4180_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1233613","volume":"14","author":"K Porwal","year":"2023","unstructured":"K. Porwal, S. Sharma, S. Kumar, M.S. Tomar, S. Sadhukhan, S. Rajput, C. Kulkarni, A. Shrivastava, N. Kumar, N. Chattopadhyay, Hormonal and non-hormonal oral contraceptives given long-term to pubertal rats differently affect bone mass, quality and metabolism. Front. Endocrinol. 14, 1233613 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1233613","journal-title":"Front. Endocrinol."},{"key":"4180_CR37","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00198-022-06366-2","volume":"33","author":"S Sharma","year":"2022","unstructured":"S. Sharma, P. Mehta, A. Patil, S.K. Gupta, S. Rajender, N. Chattopadhyay, Meta-analyses of the quantitative computed tomography data in dialysis patients show differential impacts of renal failure on the trabecular and cortical bones. Osteoporos. Int. 33, 1521\u20131533 (2022). https:\/\/doi.org\/10.1007\/s00198-022-06366-2","journal-title":"Osteoporos. Int."},{"key":"4180_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.775066","volume":"12","author":"Y Xiong","year":"2021","unstructured":"Y. Xiong, T. He, Y. Wang, W.V. Liu, S. Hu, Y. Zhang, D. Wen, B. Hou, Y. Li, P. Zhang, J. Liu, F. He, X. Li, CKD stages, bone metabolism markers, and cortical porosity index: Associations and Mediation effects analysis. Front. Endocrinol. 12, 775066 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.775066","journal-title":"Front. Endocrinol."},{"key":"4180_CR39","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/jbmr.485","volume":"26","author":"SM Moe","year":"2011","unstructured":"S.M Moe, J.S Radcliffe, K.E White, V.H. Gattone 2nd, M.F. Seifert, X. Chen, B. Aldridge, N.X. Chen, The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat. J. Bone Miner. Res. 26, 2672\u20132681 (2011). https:\/\/doi.org\/10.1002\/jbmr.485.","journal-title":"J. Bone Miner. Res."},{"key":"4180_CR40","doi-asserted-by":"publisher","first-page":"e0180430","DOI":"10.1371\/journal.pone.0180430","volume":"12","author":"A Yaguchi","year":"2017","unstructured":"A. Yaguchi, S. Tatemichi, H. Takeda, M. Kobayashi, PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure. PLoS One 12, e0180430 (2017). https:\/\/doi.org\/10.1371\/journal.pone.0180430","journal-title":"PLoS One"},{"key":"4180_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.11005\/jbm.2018.25.3.153","volume":"25","author":"A Ghorbanihaghjo","year":"2018","unstructured":"A. Ghorbanihaghjo, H. Argani, Z. Golmohamadi, N. Rashtchizadeh, M.M. Abbasi, N. Bargahi, A.M. Vatankhah, D. Sanajou, Linkage of fibroblast growth factor 23 and phosphate in serum: phosphate and fibroblast growth factor 23 reduction by increasing dose of sevelamer. J. Bone Metab. 25, 153\u2013159 (2018). https:\/\/doi.org\/10.11005\/jbm.2018.25.3.153","journal-title":"J. Bone Metab."},{"key":"4180_CR42","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","volume":"70","author":"M Jadoul","year":"2006","unstructured":"M. Jadoul, J.M. Albert, T. Akiba, T. Akizawa, L. Arab, J.L. Bragg-Gresham, N. Mason, K.G. Prutz, E.W. Young, R.L. Pisoni, Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int. 70, 1358\u20131366 (2006). https:\/\/doi.org\/10.1038\/sj.ki.5001754","journal-title":"Kidney Int."},{"key":"4180_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2020.100297","volume":"13","author":"I Ruderman","year":"2020","unstructured":"I. Ruderman, C.S. Rajapakse, A. Opperman, P.L. Robertson, R. Masterson, M.K. Tiong, N.D. Toussaint, Bone microarchitecture in patients undergoing parathyroidectomy for management of secondary hyperparathyroidism. Bone Rep. 13, 100297 (2020). https:\/\/doi.org\/10.1016\/j.bonr.2020.100297","journal-title":"Bone Rep."},{"key":"4180_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/tcmj.tcmj_212_23","volume":"36","author":"GT Yiang","year":"2024","unstructured":"G.T. Yiang, W.L. Su, C.M. Zheng, M.T. Liao, T.H. Cheng, C.L. Lu, K.C. Lu, The influence of uremic toxins on low bone turnover disease in chronic kidney disease. Tzu Chi Med. J. 36, 38\u201345 (2024). https:\/\/doi.org\/10.4103\/tcmj.tcmj_212_23","journal-title":"Tzu Chi Med. J."},{"key":"4180_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/toxins11050279","volume":"11","author":"Y Bennis","year":"2019","unstructured":"Y. Bennis, Y. Cluet, D. Titeca-Beauport, N. El Esper, P. Ure\u00f1a, S. Bodeau, C. Combe, B. Dussol, D. Fouque, G. Choukroun, S. Liabeuf, The effect of sevelamer on serum levels of gut-derived uremic toxins: results from in vitro experiments and a multicenter, double-blind, placebo-controlled, randomized clinical trial. Toxins 11, 279 (2019). https:\/\/doi.org\/10.3390\/toxins11050279","journal-title":"Toxins"},{"key":"4180_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11926-016-0574-z","volume":"18","author":"E Mitton-Fitzgerald","year":"2016","unstructured":"E. Mitton-Fitzgerald, C.M. Gohr, B. Bettendorf, A.K. Rosenthal, The role of ANK in calcium pyrophosphate deposition disease. Curr. Rheumatol. Rep. 18, 25 (2016). https:\/\/doi.org\/10.1007\/s11926-016-0574-z","journal-title":"Curr. Rheumatol. Rep."},{"key":"4180_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115656","volume":"142","author":"ND Maulding","year":"2021","unstructured":"N.D. Maulding, D. Kavanagh, K. Zimmerman, G. Coppola, T.O. Carpenter, N.K. Jue, D.T. Braddock, Genetic pathways disrupted by ENPP1 deficiency provide insight into mechanisms of osteoporosis, osteomalacia, and paradoxical mineralization. Bone 142, 115656 (2021). https:\/\/doi.org\/10.1016\/j.bone.2020.115656","journal-title":"Bone"},{"key":"4180_CR48","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s11010-022-04429-w","volume":"477","author":"CL Bartlett","year":"2022","unstructured":"C.L. Bartlett, E.M. Cave, N.J. Crowther, W.F. Ferris, A new perspective on the function of tissue non-specific alkaline phosphatase: from bone mineralization to intra-cellular lipid accumulation. Mol. Cell. Biochem. 477, 2093\u20132106 (2022). https:\/\/doi.org\/10.1007\/s11010-022-04429-w","journal-title":"Mol. Cell. Biochem."},{"key":"4180_CR49","doi-asserted-by":"publisher","first-page":"e42329","DOI":"10.1371\/journal.pone.0042329","volume":"7","author":"A Rangiani","year":"2012","unstructured":"A. Rangiani, Z. Cao, Y. Sun, Y. Lu, T. Gao, B. Yuan, A. Rodgers, C. Qin, O.M. Kuro, J.Q. Feng, Protective roles of DMP1 in high phosphate homeostasis. PLoS One 7, e42329 (2012). https:\/\/doi.org\/10.1371\/journal.pone.0042329","journal-title":"PLoS One"},{"key":"4180_CR50","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1002\/jbmr.2907","volume":"31","author":"CY Yoon","year":"2016","unstructured":"C.Y. Yoon, J. Park, C. Seo, B.Y. Nam, S. Kim, Y.K. Kee, M. Lee, M.U. Cha, H. Kim, S. Park, H.R. Yun, S.Y. Jung, J.H. Jhee, Y.E. Kwon, M. Wu, J.E. Um, H.Y. Kang, J.T. Park, S.H. Han, S.W. Kang, H.C. Kim, S. Park, S.K. Lim, T.H. Yoo, Low dentin matrix protein 1 is associated with incident cardiovascular events in peritoneal dialysis patients. J. Bone Miner. Res. 31, 2149\u20132158 (2016). https:\/\/doi.org\/10.1002\/jbmr.2907","journal-title":"J. Bone Miner. Res."},{"key":"4180_CR51","doi-asserted-by":"publisher","first-page":"e18488","DOI":"10.7759\/cureus.18488","volume":"13","author":"N Tasnim","year":"2021","unstructured":"N. Tasnim, P. Dutta, J. Nayeem, P. Masud, A. Ferdousi, A.S. Ghosh, M. Hossain, S. Rajia, K.T. Kubra, M. Sakibuzzaman, A.T. Khan, Osteoporosis, an inevitable circumstance of chronic kidney disease: a systematic review. Cureus 13, e18488 (2021). https:\/\/doi.org\/10.7759\/cureus.18488","journal-title":"Cureus"},{"key":"4180_CR52","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1359\/jbmr.041221","volume":"20","author":"P Raggi","year":"2005","unstructured":"P. Raggi, G. James, S.K. Burke, J. Bommer, S. Chasan-Taber, H. Holzer, J. Braun, G.M. Chertow, Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. J. Bone Miner. Res. 20, 764\u2013772 (2005). https:\/\/doi.org\/10.1359\/jbmr.041221","journal-title":"J. Bone Miner. Res."},{"key":"4180_CR53","doi-asserted-by":"publisher","unstructured":"V.M. Brandenburg, W. Jahnen-Dechent, M. Ketteler, Sevelamer and the bone-vascular axis in chronic kidney disease: bone turnover, inflammation, and calcification regulation. Kidney Int Suppl., S26\u2013S33 (2009). https:\/\/doi.org\/10.1038\/ki.2009.404","DOI":"10.1038\/ki.2009.404"},{"key":"4180_CR54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bone.2015.07.015","volume":"81","author":"Y Iwasaki","year":"2015","unstructured":"Y. Iwasaki, J.J. Kazama, H. Yamato, A. Matsugaki, T. Nakano, M. Fukagawa, Altered material properties are responsible for bone fragility in rats with chronic kidney injury. Bone 81, 247\u2013254 (2015). https:\/\/doi.org\/10.1016\/j.bone.2015.07.015","journal-title":"Bone"},{"key":"4180_CR55","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/jbmr.10","volume":"25","author":"H Isaksson","year":"2010","unstructured":"H. Isaksson, M.J. Turunen, L. Rieppo, S. Saarakkala, I.S. Tamminen, J. Rieppo, H. Kr\u00f6ger, J.S. Jurvelin, Infrared spectroscopy indicates altered bone turnover and remodeling activity in renal osteodystrophy. J. Bone Miner. Res. 25, 1360\u20131366 (2010). https:\/\/doi.org\/10.1002\/jbmr.10","journal-title":"J. Bone Miner. Res."},{"key":"4180_CR56","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.bone.2006.06.008","volume":"39","author":"BR McCreadie","year":"2006","unstructured":"B.R. McCreadie, M.D. Morris, T.C. Chen, D. Sudhaker Rao, W.F. Finney, E. Widjaja, S.A. Goldstein, Bone tissue compositional differences in women with and without osteoporotic fracture. Bone 39, 1190\u20131195 (2006). https:\/\/doi.org\/10.1016\/j.bone.2006.06.008","journal-title":"Bone"},{"key":"4180_CR57","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/s8756-3282(00)00362-8","volume":"27","author":"SJ Gadeleta","year":"2000","unstructured":"S.J. Gadeleta, A.L. Boskey, E. Paschalis, C. Carlson, F. Menschik, T. Baldini, M. Peterson, C.M. Rimnac, A physical, chemical, and mechanical study of lumbar vertebrae from normal, ovariectomized, and nandrolone decanoate-treated cynomolgus monkeys (Macaca fascicularis). Bone 27, 541\u2013550 (2000). https:\/\/doi.org\/10.1016\/s8756-3282(00)00362-8","journal-title":"Bone"},{"key":"4180_CR58","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/jmsr.jmsr_31_20","volume":"4","author":"M Khalid","year":"2020","unstructured":"M. Khalid, F. Khan, M.S. Baik, J. Fazal, Should bone densitometry define osteoporosis in 2020? a current concepts review of the role of vibrational spectroscopy in the evaluation of bone health. J. Musculoskelet. Surg. Res. 4, 118 (2020).","journal-title":"J. Musculoskelet. Surg. Res."},{"key":"4180_CR59","first-page":"114","volume":"17","author":"NH Hart","year":"2017","unstructured":"N.H. Hart, S. Nimphius, T. Rantalainen, A. Ireland, A. Siafarikas, R.U. Newton, Mechanical basis of bone strength: influence of bone material, bone structure and muscle action. J. Musculoskelet. Neuronal Interact. 17, 114\u2013139 (2017).","journal-title":"J. Musculoskelet. Neuronal Interact."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04180-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04180-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04180-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T03:47:39Z","timestamp":1747021659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04180-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["4180"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04180-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}